Sankar D Navaneethan
Overview
Explore the profile of Sankar D Navaneethan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
254
Citations
13461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Martin S, Aday A, Almarzooq Z, Anderson C, Arora P, Avery C, et al.
Circulation
. 2024 Jan;
149(8):e347-e913.
PMID: 38264914
Background: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including...
12.
Arney J, Gregg L, Wydermyer S, Herrera M, Richardson P, Matheny M, et al.
Cardiorenal Med
. 2023 Dec;
14(1):34-44.
PMID: 38151011
Introduction: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) improve outcomes but are underutilized in patients with chronic kidney disease (CKD). Little is known about reasons for discontinuation and...
13.
Amir S, Kim H, Hu E, Ricardo A, Mills K, He J, et al.
Am J Kidney Dis
. 2023 Dec;
83(5):624-635.
PMID: 38103719
Rationale & Objective: Studies have shown that generally healthy individuals who consume diets rich in plant foods have a lower risk of incident chronic kidney disease (CKD) and cardiovascular disease....
14.
Navaneethan S, Mitch W
J Am Soc Nephrol
. 2023 Nov;
35(1):1-2.
PMID: 38015564
No abstract available.
15.
Ella K, Navaneethan S
Curr Opin Nephrol Hypertens
. 2023 Aug;
32(5):401-403.
PMID: 37530083
No abstract available.
16.
Gregg L, Worsley M, Ramsey D, Segar M, Matheny M, Virani S, et al.
Clin J Am Soc Nephrol
. 2023 Jul;
18(11):1479-1482.
PMID: 37490295
No abstract available.
17.
Sun D, Targher G, Byrne C, Wheeler D, Wong V, Fan J, et al.
Hepatobiliary Surg Nutr
. 2023 Jun;
12(3):386-403.
PMID: 37351121
Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident....
18.
Gregg L, Richardson P, Herrera M, Akeroyd J, Jafry S, Gobbel G, et al.
Am J Nephrol
. 2023 May;
54(3-4):126-135.
PMID: 37231800
Introduction: Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) are frequently discontinued in patients with chronic kidney disease (CKD). Documented adverse drug reactions (ADRs) in medical records may provide...
19.
Hussain A, Ramsey D, Lee M, Mahtta D, Khan M, Nambi V, et al.
JACC Heart Fail
. 2023 May;
11(8 Pt 1):933-942.
PMID: 37204363
Background: Multiple clinical trials have demonstrated significant cardiovascular benefit with use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with type 2 diabetes (T2DM) and heart failure (HF) irrespective of ejection...
20.
Walther C, Navaneethan S
Kidney Int
. 2023 Apr;
103(5):837-839.
PMID: 37085257
Japanese and US populations have similar chronic kidney disease prevalence but differing clinical outcomes. A secondary analysis compared cardiovascular outcomes in a Japanese- and a US-based chronic kidney disease cohort...